Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …

Following the advancement of the Positron Emission Tomography (PET), a novel technique
emerged which takes advantage of the gamma quanta emitted, in some cases, after the β+ …

The positron emitters 18F, 68Ga, 124I, and 89Zr are all relevant in small-animal PET. Each
of these radionuclides has different positron energies and ranges and a different fraction of …

Tumor uptake of copper (II)-diacetyl-bis (N 4-methylthiosemicarbazone)(copper-ATSM), a
hypoxia-targeting radiopharmaceutical, assessed by PET has been found to correlate with …

BACKGROUND: Dynamic biomedical research is currently yielding a wealth of information
about disease-associated molecular alterations on cell surfaces and in the extracellular …

INTRODUCTION: The shortage of reactor-produced molybdenum-99 (99Mo, t½= 66 h) has
renewed interest in alternative production methods of its daughter isotope, technetium-99m …

Abstract Positron-emission-tomography (PET) has become an indispensable diagnostic tool
in modern nuclear medicine. Its outstanding molecular imaging features allow repetitive …

There is growing interest in the large scale cyclotron production of 99mTc via the 100Mo (p,
2n) 99mTc reaction. While the use and recycling of cyclotron-irradiated enriched …

Solutions containing a high concentration (0.325–0.995 g/ml) of natural-abundance
ammonium heptamolybdate tetrahydrate ((NH4) 6Mo7O24)· 4H2O were irradiated at 13MeV …

Non-standard positron emission tomography (PET) nuclides bring with them the prospect of
new chemistry leading the way to novel approaches for targeted imaging and therapy. In …